Setting the standard through dynamic genomic technology platform, improving patient outcomes AURORA, Colo., /PRNewswire/ -- ...

Vigil is the first cellular immunotherapy to demonstrate longer-term survival benefits in a randomized controlled trial of patients with solid tumors. The results of the company's Phase 2b study have ...

Dear reader, many people imagine that our bodies belong solely to us. In reality, however, we carry within us countless ...

Scientists have identified both a new species and genus of sunflower in the Texas desert, but climate change may threaten its ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

The second act of a popular reprogramming factor could maximize the potential of iPSCs in research and regenerative medicine.

Discover how AI is shaping the future of forensic science, from crime scene reconstruction to DNA analysis. Explore the ...

A new collaboration between the MHRA and Barts Health NHS Trust has led to introduction a new DNA sequencing technology ...

DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA. Sanger sequencing by replicative synthesis in the presence of ...

Using current technological and scientific advances, we are able to observe a snapshot of a plant group that is rapidly ...

A team of scientists built a computer model of a critical NER component called the pre-incision complex (PInC) that plays a ...

Quantum-Si aims to revolutionize protein sequencing amidst technological hurdles, uncertain advancements, and market ...